クローン病（CD）治療の世界市場レポート 2025年

クローン病（CD）治療市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR5.0％で150億6,000万米ドルに成長します。予測期間の成長は、併用療法の需要拡大、生物学的製剤の採用拡大、クローン病（cd）治療に関する研究開発への投資などに起因すると考えられます。予測期間における主な動向には、生物学的製剤の開発、革新的な製品、高度な診断ツール、バイオシミラーの採用などがあります。

炎症性腸疾患の有病率の上昇は、今後数年間のクローン病（CD）治療市場の成長を牽引すると予想されます。炎症性腸疾患（IBD）は、主に胃腸（GI）管に影響を及ぼす慢性炎症性疾患群を包含します。クローン病（CD）の治療は、症状を緩和し、炎症を抑え、寛解を促し、慢性炎症性腸疾患に罹患した人の全体的な生活の質を改善するのに役立ちます。例えば、米国に本部を置く医学図書館である米国国立医学図書館は2023年9月、カナダにおけるIBDの罹患率を10万人年当たり30例と推定しており、毎年約0.58％ずつ着実に増加すると予測しています。2023年現在、カナダにおけるIBDの有病率は10万人当たり約825人に達し、2035年には人口の1.1％まで増加するとの予測もあります。このように、炎症性腸疾患の有病率の増加がクローン病（CD）治療に対する需要を牽引しています。

クローン病治療市場の成長が見込まれる背景には、臨床試験の増加があります。臨床試験は、新しい治療法の安全性と有効性を評価するために極めて重要であり、規制当局の承認やクローン病（CD）患者に対する新しい治療法の導入につながる可能性があります。より効率的なクローン病治療への需要が臨床試験を後押しし、患者やヘルスケアプロバイダーが副作用を軽減して治療成績を向上させたいという願望が、研究開発の努力を促しています。例えば、カリフォルニア大学は、小児CDおよび潰瘍性大腸炎患者を対象としたvedolizumab、経口オザニモド、ミリキズマブの長期有効性に焦点を当てた17の進行中の臨床試験を報告し、この疾患における臨床試験の急増を強調しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界クローン病（CD）治療PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のクローン病（CD）治療市場：成長率分析
• 世界のクローン病（CD）治療市場の実績：規模と成長, 2019-2024
• 世界のクローン病（CD）治療市場の予測：規模と成長, 2024-2029, 2034F
• 世界クローン病（CD）治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のクローン病（CD）治療市場薬の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗生物質
• アミノサリチル酸
• コルチコステロイド
• 免疫調節薬
• その他の薬物の種類
• 世界のクローン病（CD）治療市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• オーラル
• 注射可能
• 世界のクローン病（CD）治療市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• オンライン薬局
• ドラッグストア
• 世界のクローン病（CD）治療市場抗生物質の種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• メトロニダゾール
• シプロフロキサシン
• リファキシミン
• 世界のクローン病（CD）治療市場、アミノサリチル酸のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• メサラミン
• スルファサラジン
• 世界のクローン病（CD）治療市場、コルチコステロイドのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• プレドニゾン
• ブデソニド
• ヒドロコルチゾン
• 世界のクローン病（CD）治療市場、免疫調節剤の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• アザチオプリン
• メルカプトプリン
• メトトレキサート
• 世界のクローン病（CD）治療市場、その他の薬剤タイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 生物学的療法
• ヤヌスキナーゼ阻害剤
• 小分子

第7章 地域別・国別分析

• 世界のクローン病（CD）治療市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のクローン病（CD）治療市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• クローン病（CD）治療市場：競合情勢
• クローン病（CD）治療市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson and Johnson Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Merck and Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Sanofi S.A.
• Bristol-Myers Squibb Company
• Abbott Laboratories
• GlaxoSmithKline Plc
• Takeda Pharmaceutical Company Limited
• Eli Lilly and Company
• Amgen Inc.
• Boehringer Ingelheim International GmbH
• Teva Pharmaceutical Industries Ltd.
• Mylan N.V.
• Bausch Health Companies Inc.
• UCB S.A.
• Sun Pharmaceutical Industries Ltd.
• Perrigo Company PLC
• Dr. Reddy's Laboratories Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• クローン病（CD）治療市場2029：新たな機会を提供する国
• クローン病（CD）治療市場2029：新たな機会を提供するセグメント
• クローン病（CD）治療市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Crohn's disease (CD) is an inflammatory bowel disease (IBD) that causes inflammation and swelling of the tissues in the digestive tract. Crohn's disease (CD) treatment involves various approaches, therapies, medications and interventions to manage and control the symptoms and complications of a chronic inflammatory condition.

The primary categories of drugs used in the treatment of Crohn's disease are antibiotics, aminosalicylates, corticosteroids, immunomodulators, and other types of medications. Antibiotics are drugs that combat bacterial infections by either killing the bacteria or inhibiting their growth and reproduction. These drugs can be administered orally or via injection, and they are distributed through hospital pharmacies, retail pharmacies, online pharmacies, and drug stores.

The Crohn's disease treatment market research report is one of a series of new reports from The Business Research Company that provides Crohn's disease treatment market statistics, including Crohn's disease treatment industry global market size, regional shares, competitors with a Crohn's disease treatment market share, detailed Crohn's disease treatment market segments, market trends and opportunities and any further data you may need to thrive in the Crohn's disease treatment industry. This Crohn's disease treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The crohn's disease (CD) treatment market size has grown strongly in recent years. It will grow from $11.76 billion in 2024 to $12.38 billion in 2025 at a compound annual growth rate (CAGR) of 5.3%. The growth in the historic period can be attributed to rising prevalence of crohn's disease, growing awareness of the disease, government initiatives, changing lifestyle.

The crohn's disease (CD) treatment market size is expected to see strong growth in the next few years. It will grow to $15.06 billion in 2029 at a compound annual growth rate (CAGR) of 5.0%. The growth in the forecast period can be attributed to growing demand for combination therapies, increasing adoption of biologics, investments in research and development on crohn's disease (cd) treatments. Major trends in the forecast period include development biologic drugs, innovative products, advanced diagnostic tools, biosimilars adoption.

The rising prevalence of inflammatory bowel diseases is expected to drive the growth of the Crohn's disease (CD) treatment market in the coming years. Inflammatory bowel disease (IBD) encompasses a group of chronic inflammatory conditions that primarily affect the gastrointestinal (GI) tract. Treatments for Crohn's disease (CD) help alleviate symptoms, reduce inflammation, encourage remission, and improve the overall quality of life for individuals affected by chronic inflammatory bowel disease. For example, in September 2023, the United States National Library of Medicine, a medical library based in the US, estimated that the incidence of IBD in Canada was 30 cases per 100,000 person-years in 2023, with projections showing a steady annual increase of about 0.58%. As of 2023, the prevalence of IBD in Canada reached approximately 825 per 100,000, with predictions indicating it could rise to 1.1% of the population by 2035. Thus, the growing prevalence of inflammatory bowel diseases is driving the demand for Crohn's disease (CD) treatments.

Anticipated growth in the Crohn's disease treatment market can be attributed to the increasing number of clinical trials. Clinical trials are crucial for assessing the safety and effectiveness of new therapies, potentially leading to regulatory approvals and the introduction of novel treatment options for Crohn's disease (CD) patients. The demand for more efficient CD treatments encourages clinical trials, driven by the desire of patients and healthcare providers for improved outcomes with reduced side effects, thereby stimulating research and development endeavors. For example, the University of California reported 17 ongoing clinical trials focused on vedolizumab, oral ozanimod, and the long-term efficacy of mirikizumab for pediatric CD and ulcerative colitis patients, highlighting the proliferation of clinical trials in the fie

Leading companies in the Crohn's disease (CD) treatment market are focused on the introduction of innovative technologies like IBDSENSE to maintain their market position. An example of this is the development of IBDSENSE by The IRR Chemistry Hub, an interdisciplinary hub based in Scotland. IBDSENSE is designed to enhance the diagnosis and monitoring of inflammatory bowel diseases, including Crohn's disease, through non-invasive methods. The technology utilizes fluorescence-based techniques to measure the enzyme activity of Granzyme B (GzmB) in patient biosamples, aiming to enhance the patient experience and treatment options.

In June 2023, Merck & Co. Inc., a pharmaceutical company based in the United States, completed its acquisition of Prometheus Biosciences Inc. for a total of $10.8 billion. This strategic move by Merck & Co. is intended to broaden its range of products related to the treatment of immunological and inflammatory conditions. Prometheus Biosciences, a biotechnology company based in the United States, specializes in the development of drugs for inflammatory diseases, particularly in the areas of Crohn's disease and inflammatory bowel disease treatments.

Major companies operating in the crohn's disease (cd) treatment market are Pfizer Inc., Johnson and Johnson Ltd., Merck and Co. Inc., AbbVie Inc., Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, Abbott Laboratories, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Mylan N.V., Bausch Health Companies Inc., UCB S.A., Sun Pharmaceutical Industries Ltd., Perrigo Company PLC, Dr. Reddy's Laboratories Ltd., Aurobindo Pharma Limited, Cipla Limited, Ferring B.V., Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC.

North America was the largest region in the Crohn's disease (CD) treatment market in 2024. The regions covered in Crohn's disease (CD) treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the Crohn's disease (CD) treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The Crohn's disease (CD) treatment market consists of sales of Janus kinase inhibitors and anti-inflammatory drugs. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Crohn's Disease (CD) Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on crohn's disease (cd) treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for crohn's disease (cd) treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The crohn's disease (cd) treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Drug Type: Antibiotics; Amino Salicylates; Corticosteroids; Immunomodulators; Other Drug Types
• 2) By Route of Administration: Oral; Injectable
• 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Drug Stores
• Subsegments:
• 1) By Antibiotics: Metronidazole; Ciprofloxacin; Rifaximin
• 2) By Amino Salicylates: Mesalamine; Sulfasalazine
• 3) By Corticosteroids: Prednisone; Budesonide; Hydrocortisone
• 4) By Immunomodulators: Azathioprine; Mercaptopurine; Methotrexate
• 5) By Other Drug Types: Biologic Therapies; Janus Kinase Inhibitors; Small Molecules
• Companies Mentioned: Pfizer Inc.; Johnson and Johnson Ltd.; Merck and Co. Inc.; AbbVie Inc.; Novartis AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Crohn's Disease (CD) Treatment Market Characteristics

3. Crohn's Disease (CD) Treatment Market Trends And Strategies

4. Crohn's Disease (CD) Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Crohn's Disease (CD) Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Crohn's Disease (CD) Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Crohn's Disease (CD) Treatment Market Growth Rate Analysis
• 5.4. Global Crohn's Disease (CD) Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Crohn's Disease (CD) Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Crohn's Disease (CD) Treatment Total Addressable Market (TAM)

6. Crohn's Disease (CD) Treatment Market Segmentation

• 6.1. Global Crohn's Disease (CD) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antibiotics
• Amino Salicylates
• Corticosteroids
• Immunomodulators
• Other Drug Types
• 6.2. Global Crohn's Disease (CD) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Injectable
• 6.3. Global Crohn's Disease (CD) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Drug Stores
• 6.4. Global Crohn's Disease (CD) Treatment Market, Sub-Segmentation Of Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Metronidazole
• Ciprofloxacin
• Rifaximin
• 6.5. Global Crohn's Disease (CD) Treatment Market, Sub-Segmentation Of Amino Salicylates, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mesalamine
• Sulfasalazine
• 6.6. Global Crohn's Disease (CD) Treatment Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Prednisone
• Budesonide
• Hydrocortisone
• 6.7. Global Crohn's Disease (CD) Treatment Market, Sub-Segmentation Of Immunomodulators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Azathioprine
• Mercaptopurine
• Methotrexate
• 6.8. Global Crohn's Disease (CD) Treatment Market, Sub-Segmentation Of Other Drug Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Biologic Therapies
• Janus Kinase Inhibitors
• Small Molecules

7. Crohn's Disease (CD) Treatment Market Regional And Country Analysis

• 7.1. Global Crohn's Disease (CD) Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Crohn's Disease (CD) Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Crohn's Disease (CD) Treatment Market

• 8.1. Asia-Pacific Crohn's Disease (CD) Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Crohn's Disease (CD) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Crohn's Disease (CD) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Crohn's Disease (CD) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Crohn's Disease (CD) Treatment Market

• 9.1. China Crohn's Disease (CD) Treatment Market Overview
• 9.2. China Crohn's Disease (CD) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Crohn's Disease (CD) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Crohn's Disease (CD) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Crohn's Disease (CD) Treatment Market

• 10.1. India Crohn's Disease (CD) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Crohn's Disease (CD) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Crohn's Disease (CD) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Crohn's Disease (CD) Treatment Market

• 11.1. Japan Crohn's Disease (CD) Treatment Market Overview
• 11.2. Japan Crohn's Disease (CD) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Crohn's Disease (CD) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Crohn's Disease (CD) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Crohn's Disease (CD) Treatment Market

• 12.1. Australia Crohn's Disease (CD) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Crohn's Disease (CD) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Crohn's Disease (CD) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Crohn's Disease (CD) Treatment Market

• 13.1. Indonesia Crohn's Disease (CD) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Crohn's Disease (CD) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Crohn's Disease (CD) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Crohn's Disease (CD) Treatment Market

• 14.1. South Korea Crohn's Disease (CD) Treatment Market Overview
• 14.2. South Korea Crohn's Disease (CD) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Crohn's Disease (CD) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Crohn's Disease (CD) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Crohn's Disease (CD) Treatment Market

• 15.1. Western Europe Crohn's Disease (CD) Treatment Market Overview
• 15.2. Western Europe Crohn's Disease (CD) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Crohn's Disease (CD) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Crohn's Disease (CD) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Crohn's Disease (CD) Treatment Market

• 16.1. UK Crohn's Disease (CD) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Crohn's Disease (CD) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Crohn's Disease (CD) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Crohn's Disease (CD) Treatment Market

• 17.1. Germany Crohn's Disease (CD) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Crohn's Disease (CD) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Crohn's Disease (CD) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Crohn's Disease (CD) Treatment Market

• 18.1. France Crohn's Disease (CD) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Crohn's Disease (CD) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Crohn's Disease (CD) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Crohn's Disease (CD) Treatment Market

• 19.1. Italy Crohn's Disease (CD) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Crohn's Disease (CD) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Crohn's Disease (CD) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Crohn's Disease (CD) Treatment Market

• 20.1. Spain Crohn's Disease (CD) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Crohn's Disease (CD) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Crohn's Disease (CD) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Crohn's Disease (CD) Treatment Market

• 21.1. Eastern Europe Crohn's Disease (CD) Treatment Market Overview
• 21.2. Eastern Europe Crohn's Disease (CD) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Crohn's Disease (CD) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Crohn's Disease (CD) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Crohn's Disease (CD) Treatment Market

• 22.1. Russia Crohn's Disease (CD) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Crohn's Disease (CD) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Crohn's Disease (CD) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Crohn's Disease (CD) Treatment Market

• 23.1. North America Crohn's Disease (CD) Treatment Market Overview
• 23.2. North America Crohn's Disease (CD) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Crohn's Disease (CD) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Crohn's Disease (CD) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Crohn's Disease (CD) Treatment Market

• 24.1. USA Crohn's Disease (CD) Treatment Market Overview
• 24.2. USA Crohn's Disease (CD) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Crohn's Disease (CD) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Crohn's Disease (CD) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Crohn's Disease (CD) Treatment Market

• 25.1. Canada Crohn's Disease (CD) Treatment Market Overview
• 25.2. Canada Crohn's Disease (CD) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Crohn's Disease (CD) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Crohn's Disease (CD) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Crohn's Disease (CD) Treatment Market

• 26.1. South America Crohn's Disease (CD) Treatment Market Overview
• 26.2. South America Crohn's Disease (CD) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Crohn's Disease (CD) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Crohn's Disease (CD) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Crohn's Disease (CD) Treatment Market

• 27.1. Brazil Crohn's Disease (CD) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Crohn's Disease (CD) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Crohn's Disease (CD) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Crohn's Disease (CD) Treatment Market

• 28.1. Middle East Crohn's Disease (CD) Treatment Market Overview
• 28.2. Middle East Crohn's Disease (CD) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Crohn's Disease (CD) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Crohn's Disease (CD) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Crohn's Disease (CD) Treatment Market

• 29.1. Africa Crohn's Disease (CD) Treatment Market Overview
• 29.2. Africa Crohn's Disease (CD) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Crohn's Disease (CD) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Crohn's Disease (CD) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Crohn's Disease (CD) Treatment Market Competitive Landscape And Company Profiles

• 30.1. Crohn's Disease (CD) Treatment Market Competitive Landscape
• 30.2. Crohn's Disease (CD) Treatment Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson and Johnson Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck and Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Crohn's Disease (CD) Treatment Market Other Major And Innovative Companies

• 31.1. Sanofi S.A.
• 31.2. Bristol-Myers Squibb Company
• 31.3. Abbott Laboratories
• 31.4. GlaxoSmithKline Plc
• 31.5. Takeda Pharmaceutical Company Limited
• 31.6. Eli Lilly and Company
• 31.7. Amgen Inc.
• 31.8. Boehringer Ingelheim International GmbH
• 31.9. Teva Pharmaceutical Industries Ltd.
• 31.10. Mylan N.V.
• 31.11. Bausch Health Companies Inc.
• 31.12. UCB S.A.
• 31.13. Sun Pharmaceutical Industries Ltd.
• 31.14. Perrigo Company PLC
• 31.15. Dr. Reddy's Laboratories Ltd.

32. Global Crohn's Disease (CD) Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Crohn's Disease (CD) Treatment Market

34. Recent Developments In The Crohn's Disease (CD) Treatment Market

35. Crohn's Disease (CD) Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Crohn's Disease (CD) Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Crohn's Disease (CD) Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Crohn's Disease (CD) Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer